Ardelyx Inc (ARDX)

Jun 2, 2025, 4:05 PM EDT - 2 days ago

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

May 21, 2025, 8:00 AM EDT - 14 days ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

May 6, 2025, 8:01 AM EDT - 4 weeks ago

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

May 2, 2025, 10:07 AM EDT - 4 weeks ago

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

May 1, 2025, 10:06 PM EDT - 4 weeks ago

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:01 PM EDT - 4 weeks ago

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:00 AM EDT - 5 weeks ago

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Apr 24, 2025, 8:01 AM EDT - 5 weeks ago

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Apr 17, 2025, 8:00 AM EDT - 6 weeks ago

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 10, 2025, 4:02 PM EDT - 7 weeks ago

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Mar 31, 2025, 4:03 PM EDT - 2 months ago

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Mar 13, 2025, 8:02 AM EDT - 2 months ago

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Mar 1, 2025, 8:30 AM EST - 3 months ago

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

HTLD NTR

Feb 26, 2025, 7:00 AM EST - 3 months ago

Tenapanor Approved in China for Hyperphosphatemia

Feb 25, 2025, 4:15 PM EST - 3 months ago

Ardelyx to Participate in Upcoming Investor Conferences

Feb 24, 2025, 2:28 PM EST - 3 months ago

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

Feb 21, 2025, 4:21 PM EST - 3 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

GERN MRNA PSNL TEM

Feb 20, 2025, 2:32 PM EST - 3 months ago

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 7:30 AM EST - 3 months ago

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 19, 2025, 8:01 AM EST - 3 months ago

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Jan 30, 2025, 4:30 PM EST - 4 months ago

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Jan 13, 2025, 8:03 AM EST - 5 months ago

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Jan 6, 2025, 8:00 AM EST - 5 months ago

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 24, 2024, 6:36 AM EST - 6 months ago

Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It

Nov 20, 2024, 8:00 AM EST - 7 months ago

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 9:34 AM EST - 7 months ago

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 8, 2024, 12:31 PM EST - 7 months ago

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

Nov 5, 2024, 8:00 AM EST - 7 months ago

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

Oct 31, 2024, 11:20 PM EDT - 7 months ago

Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 4:02 PM EDT - 7 months ago

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

Oct 28, 2024, 4:05 PM EDT - 7 months ago

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting

Oct 22, 2024, 4:05 PM EDT - 8 months ago

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

Oct 17, 2024, 8:00 AM EDT - 8 months ago

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

Oct 15, 2024, 8:00 AM EDT - 8 months ago

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology's Kidney Week

Oct 14, 2024, 5:45 AM EDT - 8 months ago

Shareholders of Ardelyx, Inc. Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX

Oct 13, 2024, 11:00 AM EDT - 8 months ago

Ardelyx Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm